Oct 9, 2025 09:30AM
Nov 16, 2022 04:01PM
Nov 1, 2022 07:31AM
Nov 1, 2022 07:30AM
Oct 7, 2022 04:01PM
Sep 30, 2022 05:00PM
Sep 15, 2022 04:45PM Stealth BioTherapeutics to Participate in Upcoming Ultra-Rare Disease Events
Aug 1, 2022 08:32AM
Aug 1, 2022 08:30AM
Jul 11, 2022 05:15PM
Jun 27, 2022 07:30AM
Jun 27, 2022 07:30AM
Jun 14, 2022 07:27AM
Jun 14, 2022 07:25AM Stealth BioTherapeutics Granted Pre-NDA Meeting for Elamipretide as a Potential Treatment for Barth Syndrome
Jun 8, 2022 07:21AM
Jun 8, 2022 07:20AM
May 31, 2022 07:25AM
May 31, 2022 07:25AM
May 23, 2022 07:30AM
May 23, 2022 07:30AM
May 12, 2022 07:30AM Stealth BioTherapeutics (MITO) Receives Orphan Drug Designation from FDA for Elamipretide for Treatment of Duchenne Muscular Dystrophy
May 12, 2022 07:30AM
May 2, 2022 07:31AM
May 2, 2022 07:30AM
Apr 11, 2022 08:31AM
Apr 11, 2022 08:30AM
Mar 30, 2022 04:31PM
Mar 30, 2022 04:30PM Stealth BioTherapeutics Announces New SBT-272 Data and Trial Initiation
Mar 28, 2022 07:31AM
Mar 28, 2022 07:30AM
Mar 24, 2022 07:31AM
Mar 24, 2022 07:30AM
Mar 16, 2022 04:33PM
Mar 16, 2022 04:30PM
Feb 22, 2022 07:30AM Stealth BioTherapeutics to Present at Mitochondria-Targeted Drug Development Summit
Feb 15, 2022 07:30AM
Feb 11, 2022 05:30PM
Jan 7, 2022 04:30PM
Jan 7, 2022 04:30PM
Dec 20, 2021 07:31AM
Dec 20, 2021 07:30AM
Dec 13, 2021 07:32AM Stealth BioTherapeutics (MITO) Issues Update On Clinical Stage Rare Disease Programs
Dec 13, 2021 07:30AM
Nov 11, 2021 07:30AM
Oct 20, 2021 09:27AM
Oct 20, 2021 07:31AM
Oct 20, 2021 07:30AM
Oct 4, 2021 07:30AM
Aug 24, 2021 07:30AM Stealth BioTherapeutics (MITO) Announces Elamipretide NDA Submission
Aug 24, 2021 07:30AM

322,899 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All